NeuMoDx Molecular

company

About

NeuMoDx Molecular, Inc. operates as a molecular diagnostics company. The company develops solutions for molecular diagnostic (MDx) testing

  • Ann Arbor,Michigan,United States
  • 51 - 100

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$19.99M
Industries
Biotechnology,Health Care,Health Diagnostics,Medical
Founded date
Jan 1, 2012
Number Of Employee
51 - 100
Operating Status
Active
Legal Name
NeuMoDx Molecular, Inc.

NeuMoDx Molecular, Inc. operates as a molecular diagnostics company. The company develops solutions for molecular diagnostic (MDx) testing in hospital and clinical reference laboratories.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$66.03M
NeuMoDx Molecular has raised a total of $66.03M in funding over 2 rounds. Their latest funding was raised on May 3, 2018 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 3, 2018 Series Unknown $20.03M Detail
Apr 29, 2016 Series Unknown $19.99M Detail
Apr 1, 2014 Series B $21M 5 Baird Capital
Pfizer Venture Investments
Venture Investors
Detail
Apr 1, 2012 Series A $5M 1 Wolverine Venture Fund Detail

Investors

Number of Lead Investors
Number of Investors
4
5
NeuMoDx Molecular is funded by 5 investors. Baird Capital and Pfizer Venture Investments are the most recent investors.
Investor Name Lead Investor Funding Round
Baird Capital Yes Series B
Pfizer Venture Investments Yes Series B
Venture Investors Yes Series B
Arboretum Ventures Series B
Wolverine Venture Fund Series B

Employee Profiles

Number of Employee Profiles
2
NeuMoDx Molecular has 2 current employee profiles, including Board member Bill Burkoth
Board member
Executive